Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Dentistry / 牙醫專業學院
  4. Dentistry / 牙醫學系
  5. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and chinese medicinal herbs on patients with oral lichen planus
 
  • Details

Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and chinese medicinal herbs on patients with oral lichen planus

Journal
Journal of Oral Pathology and Medicine
Journal Volume
31
Journal Issue
4
Pages
196-203
Date Issued
2002
Author(s)
ANDY SUN 
JEAN-SAN CHIA  
JULIA YU-FONG CHANG  
CHUN-PIN CHIANG  
DOI
10.1034/j.1600-0714.2002.310402.x
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035983777&doi=10.1034%2fj.1600-0714.2002.310402.x&partnerID=40&md5=4c151a81de2469bfb3d5b6f6426f30e9
https://scholars.lib.ntu.edu.tw/handle/123456789/584901
Abstract
Background: Oral lichen planus (OLP) is a T cell-mediated inflammatory disease. Interleukin-6 (IL-6) is a pro-inflammatory cytokine that has effects on cellular and humoral immunities. Previous studies have shown that keratinocytes and tissue-infiltrating mononuclear cells from OLP lesions can secrete IL-6. In some OLP patients, the high serum IL-6 levels are reduced after treatment, suggesting that IL-6 may be a useful marker in evaluating therapeutic effects and in monitoring the disease status of OLP. Methods: In this study, we used a solid phase, two-site sequential chemiluminescent immunometric assay to determine the baseline serum levels of IL-6 in a group of 180 patients with erosive OLP (EOLP), nonerosive OLP (NEOLP), erythema multiforme (EM), traumatic ulcers (TU), oral submucous fibrosis (OSF), pemphigus vulgaris (PV), or Sj?gren's syndrome (SS), and in 77 normal control subjects. Some OLP patients were treated with levamisole plus Chinese medicinal herbs or levamisole only for 0.5-5.5 months and their serum IL-6 levels were measured after treatment. Results: We found that approximately 99% of the normal control subjects and the patients with EM, TU, or OSF had a normal serum IL-6 level less than 5.0 pg/ml. However, 15% (22/149) OLP patients, 15% (20/136) EOLP patients, 20% (5/25) major type EOLP patients, 14% (15/111) minor type EOLP patients, 15% (2/13) NEOLP patients, 14% (1/7) EM patients, 43% (3/7) PV patients, and 100% (6/6) SS patients had a serum IL-6 level greater than 5.0 pg/ml. The mean serum IL-6 level in patients with OLP (3.4 ± 3.1 pg/ml, P < 0.001), EOLP (3.4 ± 3.2 pg/ml, P < 0.001), major type EOLP (4.9 ± 3.5 pg/ml, P < 0.001), minor type EOLP (3.0 ± 3.0 pg/ml, P < 0.01), or NEOLP (4.2 ± 1.5 pg/ ml, P < 0.001) was significantly higher than that in normal control subjects (2.0 ± 1.5 pg/ml). A significant difference in the mean serum IL-6 level was also found between major type and minor type EOLP patients (P < 0.01). The mean reduction of serum IL-6 level in OLP patients treated with levamisole plus Chinese medicinal herbs was significantly higher (7.4 ± 4.7 pg/ml) than that in OLP patients treated with levamisole only (3.8 ± 2.3 pg/ml, P < 0.05), suggesting that the combination therapy was superior to levamisole only. Conclusion: We conclude that levamisole and levamisole plus Chinese medicinal herbs can modulate the serum IL-6 level in OLP patients. IL-6 may be a useful marker in evaluating therapeutic effects and in monitoring the disease status of OLP.
Subjects
Chinese medicinal herbs; Interleukin-6; Levamisole; Oral lichen planus
SDGs

[SDGs]SDG3

Other Subjects
biological marker; herbaceous agent; immunological adjuvant; interleukin 6; levamisole; Radix Astragali seu Hedysari; adolescent; adult; aged; article; blood; chemoluminescence; classification; comparative study; drug combination; erythema multiforme; female; follow up; human; injury; lichen planus; male; middle aged; mouth disease; mouth mucosa; mouth ulcer; pemphigus; phytotherapy; Sjoegren syndrome; statistics; Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Biological Markers; Chemiluminescent Measurements; Drug Combinations; Drugs, Chinese Herbal; Erythema Multiforme; Female; Follow-Up Studies; Humans; Interleukin-6; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Oral Submucous Fibrosis; Oral Ulcer; Pemphigus; Phytotherapy; Sjogren's Syndrome; Statistics
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science